Validation of a Parental Questionnaire for Screening Children for Neurovisual Disorders

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

250 participants

Study Classification

OBSERVATIONAL

Study Start Date

2025-04-01

Study Completion Date

2026-06-15

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Some children present visual difficulties linked not to damage to the eye, but to damage to the brain. This type of dysfunction of the visual cerebral pathways leads, for example, to difficulties in recognition, visuomotor coordination or visuo-spatial disorders. These highly specific disorders are known as "cortical visual impairment" (CVI). Despite their real impact on children's development, these disorders are still poorly diagnosed in the French-speaking world. As a result, follow-up and care for these children are poorly adapted. A better understanding of neurovisual disorders and the availability of validated tools in French are therefore essential. Indeed, it is currently considered that 3 to 4% of children aged four to six, i.e. around one child per kindergarten class, have a CVI following a neuro-logical lesion acquired in the perinatal period.

Because of the lack of a valid tool in French, the aim of the present study is to provide the results of a validation study of a parental questionnaire for screening children with warning signs of CVI in French. This questionnaire will be offered online using the Qualtrics tool. In order to evaluate the relevance of this questionnaire, it will be proposed, on the one hand, to parents whose child (aged 3 to 12) does not present any particular developmental difficulties, and on the other hand, to parents whose child (aged 3 to 12) seems to present signs of neurovisual disorders. By comparing their answers, the investigators hope that certain questions will reveal elements typical of neurovisual disorders/CVI, thus demonstrating the relevance of this questionnaire in facilitating diagnosis.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Neurodevelopmental Outcomes in Cerebral Visual Impairment

NCT07212010

Cerebral Visual Impairment

ENROLLING_BY_INVITATION

Cerebral/ Cortical Visual Impairment: Screening, Identification and Outcome Prediction in Neonates

NCT07275021

Preterm Less Than 32wks With IVH, WMI/PVL Late Preterm or Term (37-42wks) With Neonatal Encephalopathy Treated With Hypothermia for HIE

RECRUITING

Viewing Strategy Training in Children With (Cerebral) Visual Impairment

NCT05600140

Vision Disorders Vision, Low

RECRUITING NA

Remote Access: Cortical Visual Impairment

NCT03957980

Cortical Visual Impairment

COMPLETED NA

Cortical Visual Impairment and Visual Attentiveness

NCT00342108

Cerebral Palsy Cortical Visual Impairment

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Children Suffering From Cortical Visual Impairment

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

questionnaire

Each parent has to complete a online questionnaire

Questionnaire

Intervention Type DIAGNOSTIC_TEST

The parents have to complete a questionnaire

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Questionnaire

The parents have to complete a questionnaire

Intervention Type DIAGNOSTIC_TEST

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Parents of a child aged between 3 and 12
* Their mother tongue must be French, to ensure that they understand the questions asked in writing.

Control group:

\- Children of the parents surveyed who do not present any medical, school or family developmental particularities.

Clinical group

\- Children of the parents interviewed who present warning signs of CVI reported by a multidisciplinary team specialized in visual impairment.

Minimum Eligible Age

3 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes